Yunnan Botanee Bio-Technology Group: April 26, 2024 Investor Relations Activity Schedule
Yunnan Botanee Bio-Technology Group: 2023 Annual Financial Report
Yunnan Botanee Bio-Technology Group: 5. Inspection opinions of Guoxin Securities Co., Ltd. on Yunnan Beitney Biotechnology Group Co., Ltd.'s use of overraised capital to invest in the construction of new projects
Yunnan Botanee Bio-Technology Group: Nomination Committee Rules of Procedure (April 2024)
Yunnan Botanee Bio-Technology Group: Remuneration and Assessment Committee Rules of Procedure (April 2024)
Yunnan Botanee Bio-Technology Group: Announcement on holding the 2023 online results briefing
Yunnan Botanee Bio-Technology Group: Announcement on the estimated amount of external guarantees in 2024
Yunnan Botanee Bio-Technology Group: Announcement of Board Resolutions
Yunnan Botanee Bio-Technology Group: Legal opinion on matters relating to restricted shares not yet owned during the first vesting period of the 2023 Restricted Stock Incentive Plan that did not meet the vesting conditions and that the portion of the restricted shares that have not yet been vested has been granted
Yunnan Botanee Bio-Technology Group: Notice on convening the 2023 Annual General Meeting of Shareholders
Yunnan Botanee Bio-Technology Group: 3. Verification opinion of Guoxin Securities Co., Ltd. on the extension of some fund-raising projects of Yunnan Bethany Biotechnology Group Co., Ltd.
Yunnan Botanee Bio-Technology Group: Board of Directors Report on the 2023 Performance Evaluation Report of Accounting Firms
Yunnan Botanee Bio-Technology Group: Announcement on the company's 2023 profit distribution plan
Yunnan Botanee Bio-Technology Group: Strategy Committee Rules of Procedure (April 2024)
Yunnan Botanee Bio-Technology Group: Yunnan Beitai Biotechnology Group Co., Ltd. 2023 Internal Control and Verification Report [Tianheng Special Text (2024) 00698]
Yunnan Botanee Bio-Technology Group: 2023 Independent Director Debriefing Report-Li Ning
Yunnan Botanee Bio-Technology Group: Audit Committee Rules of Procedure (April 2024)
Yunnan Botanee Bio-Technology Group: 6. Opinions of Guoxin Securities Co., Ltd. on the verification of Yunnan Bethany Biotechnology Group Co., Ltd.'s 2024 external guarantee amount forecast
Yunnan Botanee Bio-Technology Group: Report of the Audit Committee on the performance of supervisory duties on accounting firms in 2023
Yunnan Botanee Bio-Technology Group: Announcement on the company's use of overraised capital to invest in the construction of new projects
No Data